**Core Concept**
The question tests the understanding of uronic acid metabolism and its clinical implications. Uronic acid is a product of glycosaminoglycan (GAG) degradation, and its level can be altered in certain diseases.

**Why the Correct Answer is Right**
Elevated uronic acid in urine is associated with disorders that involve the degradation of glycosaminoglycans, such as mucopolysaccharidoses. In these conditions, the deficiency of specific lysosomal enzymes leads to the accumulation and subsequent degradation of GAGs, resulting in increased uronic acid levels.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not directly relate to the degradation of glycosaminoglycans.
**Option B:** Similarly, this option is not directly associated with uronic acid metabolism.
**Option C:** This option is also incorrect as it is not related to the degradation of GAGs.

**Clinical Pearl / High-Yield Fact**
Mucopolysaccharidoses are a group of genetic disorders characterized by the deficiency of lysosomal enzymes, leading to the accumulation of glycosaminoglycans and resulting in various clinical manifestations.

**Correct Answer:** D. Mucopolysaccharidosis.